Home▸Alzheimer's Early Detection Blood Biomarker▸Neurofilament Light Chain Neurodegeneration Marker Simulator

🩸 Neurofilament Light Chain Neurodegeneration Marker Simulator

This simulation examines neurofilament light chain as a marker of neurodegeneration, allowing users to assess the extent of neuronal damage and monitor disease progression in various neurological conditions.

Alzheimer's Early Detection Blood Biomarker2DModerate60 FPS
Neurofilament Light Chain Neurodegeneration Marker Simulator ↗ Open standalone

Neurofilament Light Chain as Axonal Cytoskeleton Component

Placeholder: NfL is a core structural protein of the axonal cytoskeleton.

  • Type IV IF: Protein class (intermediate filament placeholder)
  • Axon: Location (cytoskeletal scaffold placeholder)
  • NfM / NfH: Partners (neurofilament triplet placeholder)
  • Axon caliber: Function (structural support placeholder)

Structural role placeholder heading

Placeholder text describing neurofilament light chain structural function in axons.

Release of NfL Into Blood Upon Axonal Injury

Placeholder: axonal damage releases NfL into CSF and blood.

  • Axon injury: Release trigger (placeholder mechanism)
  • CSF → blood: Compartment (placeholder pathway)
  • ~weeks: Half-life (placeholder kinetics)
  • Simoa assay: Detection (placeholder method)

Release mechanism placeholder heading

Placeholder text describing NfL release kinetics after axonal damage.

NfL as a Broad Neurodegeneration Marker

Placeholder: elevated NfL reflects neuronal damage broadly, not one disease.

  • Many: Conditions (broad marker placeholder)
  • Low: Specificity (disease-non-specific placeholder)
  • High: Sensitivity (damage detection placeholder)
  • Screening: Use (general indicator placeholder)

Specificity limitation placeholder heading

Placeholder text describing why NfL elevation is non-specific across neurodegenerative diseases.

Differentiating Alzheimer's Disease From Other Neurodegeneration

Placeholder: NfL must be combined with other markers for diagnosis.

  • Aβ42/40, p-tau: Companion markers (placeholder panel)
  • Limited: AD specificity alone (placeholder note)
  • Improved: Combined panels (placeholder accuracy)
  • FTD, ALS, MS: Overlap conditions (placeholder list)

Differential diagnosis placeholder heading

Placeholder text describing combined biomarker panels for Alzheimer's differentiation.

Serial NfL Monitoring for Disease Progression

Placeholder: repeated NfL measurement tracks progression and therapy response.

  • Months: Monitoring interval (serial sampling placeholder)
  • High: Trend value (longitudinal utility placeholder)
  • Trackable: Therapy response (placeholder application)
  • Endpoint: Trial use (clinical trial placeholder)

Longitudinal tracking placeholder heading

Placeholder text describing serial NfL monitoring for progression tracking.

Placeholder key insight about trend-based clinical value of serial NfL testing.
⚙ Under the hood

This simulation examines neurofilament light chain as a marker of neurodegeneration, allowing users to assess the extent of neuronal damage and monitor disease progression in various neurological conditions.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)